CD4-targeted CAR T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD4-targeted CAR T cell therapy, covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant [Phase 1]